000 01712cam  2200361za 4500
0019.856866
003CaOODSP
00520221107155631
007cr |||||||||||
008180523s2018    onc     o    f000 0 eng d
020 |a9780660266626
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH13-9/13-2018E-PDF
24500|aGuidance document |h[electronic resource] : |bfees for the right to sell drugs.
24630|aFees for the right to sell drugs
260 |aOttawa : |bHealth Canada, |c2018.
300 |a15 p.
500 |aIssued also in French under title: Ligne directrice : frais à payer le droit de vendre une drogue.
500 |aCover title.
500 |a"Date adopted: 1998/05. Revised date: 2018/06/13. Effective date: 2018/06/13."
500 |a"Publication date: June 2018."
500 |aIssued also in HTML format.
520 |a"This document provides guidance on the interpretation of the Fees in Respect of Drugs and Medical Devices Regulations (Fee Regulations) with a focus on how the Fees for the Right to Sell Drugs, contained in Part 2, Division 4 of these regulations, will be administered"--Introd., p. 7.
69207|2gccst|aPharmaceutical industry
69207|2gccst|aRetail trade
69207|2gccst|aGovernment policy
7101 |aCanada. |bHealth Canada.
77508|tLigne directrice |w(CaOODSP)9.856867
794 |tGuidance document : |w(CaOODSP)9.866809
85640|qPDF|s315 KB|uhttps://publications.gc.ca/collections/collection_2018/sc-hc/H13-9-13-2018-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fees/guidance-document-fees-right-sell-drugs.html